- Active cancer within 12 months prior to study entry. NOTE: Subjects with successfully treated non-melanomatous skin cancer within 12 months prior to study entry are acceptable. Disseminated Kaposi Sarcoma (visceral organ involvement) within the past 12 months is exclusionary.